Anders Rye
Process Transformation Manager at Novo Nordisk | Copenhagen, Capital Region of Denmark, Denmark
Anders Rye’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Process Transformation Manager at Novo Nordisk in January 2025 - Present
Associate Process Transformation Director at Novo Nordisk in January 2026 - Present
Strategic Lean Partner at Novo Nordisk in June 2024 - December 2024
Senior Manager in Offshore Operation at Ørsted in June 2022 - June 2024
Continuous Improvement Project Manager in Offshore Operations at Ørsted in July 2020 - June 2022
Continuous Improvement Manager and Business Process Owner of Quality Assurance processes at Maersk Drilling in March 2017 - June 2020
Process Governance Specialist and Quality Assurance Partner, Corporate Quality at Novo Nordisk in April 2013 - February 2017
Efficiency & Effectiveness Programme Manager, Corporate Relations at Novo Nordisk in October 2010 - March 2013
Lean Six Sigma Black Belt, Product Supply at Novo Nordisk in February 2008 - October 2010
LEAN 6-sigma consultant at Novo Nordisk in January 2006 - October 2010
Business Processes Graduate at Novo Nordisk in October 2004 - September 2006
Columbia Business School, Emerging Leader Development Programme, November 2026
Copenhagen Business School, Cand Merc IMM, November 2026
SKEMA Business School, Msc, November 2026
We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health. Our unordinary mindset is at the heart of everything we do. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 68,800 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to block and remove those that are off-topic, abusive or intended to spam. Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in: https://www.novonordisk.com/contact-us/find-local-information.html For other customer complaints, please contact us here: https://www.novonordisk.com/contact-us.html Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed. Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users. Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html
Discover more about Novo Nordisk
Global Director Frontline Excellence Rare Diseases, Novo Nordisk
Owner at Veum Consulting
(March 2015 – Present)
PMP® | Regulatory Affairs Project Lead (Business Area Middle East, Affrica & CIS) at Novo Nordisk
Regulatory Affairs Project Lead (Business Area Middle East, Africa &CIS) at Novo Nordisk
(January 2024 – Present)
Medical Science Liaison, Diabetes & Renal
Wine Rep at ONEHOPE Wine
(June 2021 – Present)
Public Affairs Manager presso Novo Nordisk
Public Affairs Manager at Novo Nordisk
(May 2022 – Present)
Obesity Market Access | Novo Nordisk Canada
Consultant at Global Market Access Solutions
(May 2026 – May 2026)
Associate Director – Novo Nordisk
Student in Business Partner Operation Nordic (BPO) at IBM
(January 2006 – May 2026)
What is Anders Rye email address?
Email Anders Rye at [email protected] and [email protected]. This email is the most updated Anders Rye's email found in 2026.
What is Anders Rye phone number?
Anders Rye phone number is +4530790802.
How to contact Anders Rye?
To contact Anders Rye send an email to [email protected] or [email protected]. If you want to call Anders Rye try calling on +4530790802. (updated on April 29, 2026)
What company does Anders Rye work for?
Anders Rye works for Novo Nordisk.
What is Anders Rye's role at Novo Nordisk?
Anders Rye is Process Transformation Manager
What industry does Anders Rye work in?
Anders Rye works in the Management Consulting industry.
